Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis

Journal of Travel Medicine

Volumn 11, Issue 5, 2004, Pages 328-330

  Morelli, Paola ^a   Gianelli, Erika ^a   Calattini, Sara ^a   Corbellino, Mario ^a   Antinori, Spinello ^a   Meroni, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIMONY DERIVATIVE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; PENTAMIDINE ISETHIONATE; STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; CASE REPORT; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; LEISHMANIASIS; MALE; NAUSEA; POLYMERASE CHAIN REACTION; SPOROTRICHOSIS; SUBCUTANEOUS NODULE;

EID: 8344232260     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2004.19109     Document Type: Article

References (19)

1. Davies CR, Kaye P, Croft SL, Sundar S. Leishmaniasis: new approaches to disease control. Clinical review. BMJ 2003; 326:377-382.
2. SCIEH Weekly Report. 2003; 37(No. 2003/48).
3. Gaafar A, Fadl A, el Kadero AY, et al. Sporotrichoid cutaneous leishmaniasias due to Leishmania major of different zymodemes in the Sudan and Saudi Arabia: a comparative study. Trans R Soc Trop Med Hyg 1994; 88(5):552-554.
4. Tobin EH, Jih WW. Sporotrichoid lymphocutaneous infections: etiology, diagnosis and therapy. Am Fam Physician 2001; 63(2):326-332.
5. Barral A, Barral-Netto M, Almeida R, et al. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am J Trop Med Hyg 1992; 47:587-592.
6. Walsh DS, Balagon MV, Abalos RM, et al. Multiple lesions of sporotrichoid leishmaniasis in a Filipino expatriate. J Am Acad Dermatol 1997; 36:847-849.
7. Kubba R, El-Hassan AM, Al-Gindan Y, et al. Dissemination in cutaneous leishmaniasis. I. Subcutaneous nodules. Int J Dermatol 1987; 26:300-304.
8. Al-Qurashi AR, Ghandour AM, Osman M, Al-Juma M. Dissemination in cutaneous leishmaniasis due to Leishmania major in different ethnic groups in Saudi Arabia. Int J Dermatol 2000; 39:832-836.
9. Vega-Lòpez F. Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis 2003; 16:97-101.
10. Pizzuto M, Piazza M, Senese D, et al. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients co-infected with human immunodeficiency virus type 1. J Clin Microbiol 2001; 39(1):357-361.
11. Hepburn NC. Management of cutaneous leishmaniasis. Curr Opin Infect Dis 2001; 14:151-154.
12. El Hassan AM, Zijlstra EE. Leishmaniasis in Sudan. Cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95(1):S1-S17.
13. Melby PC. Recent development in leishmaniasis. Curr Opin Infect Dis 2002; 15:485-490.
14. Herwaldt BL, Berman JD. Recommendation for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies [review]. Am J Trop Med Hyg 1992; 46:296-306.
15. Herwaldt BL. Leishmaniasis. Lancet 1999; 354:1191-1199.
16. Navin TR, Arana BA, Arana FE, et al. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165:528-534.
17. Momeni AZ, Jalayer T, Emamjomeh M, et al. Treatment of cutaneous leishmaniasis with itraconazole: randomized double-blind study. Arch Dermatol 1996; 132(7):784-786.
18. Dogra J, Saxena VN. Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease. Int J Parasitol 1996; 26:1413-1415.
19. Alrajhi AA, Ibrahim EA, De Vol EB, et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346:891-895.